D. . Bhavsar, “Adverse Event Label Expansion for GLP-1 Medications Due toOff-‎Label Use: Regulatory Implications and Challenges”, IJBAS, vol. 14, no. 8, pp. 702–709, May 2026, doi: 10.14419/n99q9v48.